Leukemia 3 Flashcards
(35 cards)
3 Myeloid Neoplasms
Acute Myelogenous Leukemia
Myelodysplastic Syndromes
Chronic Myeloproliferative Disorders
List of Lymphoid Neoplasms
Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia Follicular Lymphoma Mantle Cell Lymphoma Diffuse Large B-Cell Lymphoma Burkitt Lymphoma Multiple Myeloma and Related Plasma Cell Disorders Hodgkin Lymphoma Miscellaneous Lymphoid Neoplasms
Histiocytic Neoplasms
Langerhans Cell Histiocytoses
2 Acute leukemias
Acute lymphoblastic leukemia (ALL)
Acute myeloid (myeloblastic) leukemia (AML)
3 Chronic leukemias
Chronic lymphocytic leukemia (CLL)
Hairy cell leukemia
Chronic myelogenous leukemia (CML)
3 MYELOPROLIFERATIVE DISEASES
Polycythemia vera
Chronic idiopathic myelofibrosis (agnogenic myeloid metaplasia, myelofibrosis with myeloid metaplasia)
Essential thrombocythemia
3 Plasma cell disorder
Multiple myeloma (plasma cell myeloma/plasmacytoma)
Waldenström macroglobulinemia
Benign monoclonal gammopathy (monoclonal gammopathy of undetermined significance, or MGUS)
2 lymphoid neoplasia
Hodgkin lymphoma (Hodgkin disease)
Non-Hodgkin lymphomas
Characteristics of Plasma Cell Disorders
Plasma cell disorders are a diverse group of disorders of unknown etiology characterized by
the disproportionate proliferation of one clone of B cells and
the presence of a structurally and electrophoretically homogeneous (monoclonal) immunoglobulin or polypeptide subunit in serum, urine, or both.
Plasma cell disorders are neoplastic proliferations of well-differentiated immunoglobulin-producing cells.
These disorders include
multiple myeloma
Waldenström macroglobulinemia
benign monoclonal gammopathy
Primary amyloidosis
heavy-chain (Franklin) disease.
Occurrence is most frequent in persons older than 40–50 years of age.
Pathophysiology of Plasma Cell
1.After developing in the bone marrow, undifferentiated B cells enter peripheral lymphoid tissues, such as lymph nodes, spleen, gut, and Peyer’s patches.
2.Here, they begin to differentiate into cells, each of which can respond to a limited number of antigens.
3.After encountering the appropriate antigen, some B cells undergo clonal proliferation into plasma cells.
4.Each clonal plasma cell line is committed to synthesizing one specific immunoglobulin antibody that consists of 2 identical heavy chains (gamma [γ], mu [μ], alpha [α], delta [δ], or epsilon [ε]) and 2 identical light chains (kappa [κ] or lambda [λ]).
5. A slight excess of light chains is normally produced, and urinary excretion of small amounts of free polyclonal light chains (≤ 40 mg/24 h) is normal.
Plasma cell disorders are of unknown etiology and are characterized by the disproportionate proliferation of one clone. The result is a corresponding increase in the serum level of its product, the monoclonal immunoglobulin protein (M-protein).
M-proteins may consist of both heavy and light chains or of only one type of chain.
Some show antibody activity, which may cause autoimmune damage of organs, particularly the kidneys.
Multiple myeloma (plasma cell myeloma/plasmacytoma)
is a malignant plasma cell tumor usually affecting older persons that typically involves bone and is associated with prominent serum and urinary protein abnormalities.
Bone lesions and protein abnormalities
The neoplastic cell is an end-stage derivative of B lymphocytes that is clearly identifiable as a plasma cell. The neoplastic cells can easily be identified by bone marrow biopsy or aspiration smears.
$ The tumor cells produce lytic lesions in bone, especially in the skull and axial skeleton.
- The bone lesions appear lucent on radiographic examination, with characteristic sharp borders, and are referred to as punched-out lesions. They may be manifest radiographically as diffuse demineralization of bone (osteopenia).
- The cause is an osteoclast-activating factor secreted by the neoplastic plasma cells.
- The lesions are often associated with severe bone pain and spontaneous fractures
$$ Multiple myeloma arises from proliferation of a single clone of malignant antibody-producing cells.
Other characteristics of Multiple myeloma (plasma cell myeloma/plasmacytoma)
Multiple myeloma arises from proliferation of a single clone of malignant antibody-producing cells.
The tumor cells produce massive quantities of identical immunoglobulin molecules demonstrable electrophoretically as a narrow serum band or, after densitometric scanning, as a sharp spike referred to as an M protein.
The M protein in multiple myeloma is most often an IgG or IgA immunoglobulin of either kappa or lambda light-chain specificity.
Synthesis of normal immunoglobulins is often impaired.
The marked serum immunoglobulin increase is often initially detected by laboratory screening as increased total protein with an increase in serum globulin (hyperglobulinemia).
The urine often contains significant quantities of free immunoglobulin light chains, either kappa or lambda, which are referred to as Bence Jones protein.
As a consequence of hyperglobulinemia, the red cells tend to congregate together in a manner reminiscent of a stack of poker chips (rouleaux formation). There is also a marked increase in the erythrocyte sedimentation rate.
Clinical characteristics of Multiple myeloma (plasma cell myeloma/plasmacytoma)
Anemia due to neoplastic encroachment on myeloid precursor cells; possible leukopenia and thrombocytopenia
Increased susceptibility to infection because of impaired production of normal immunoglobulins
Hypercalcemia secondary to bone destruction; in contrast to the increased serum alkaline phosphatase that accompanies most other instances of hypercalcemia, the serum alkaline phosphatase in multiple myeloma is not increased.
Renal insufficiency with azotemia due to myeloma kidney (myeloma nephrosis). The renal lesion is characterized by prominent tubular casts of Bence Jones protein, numerous multinucleated macrophage-derived giant cells, and metastatic calcification, and sometimes by interstitial infiltration of malignant plasma cells.
Amyloidosis of the primary amyloidosis type
Signs and symptoms of Multiple myeloma (plasma cell myeloma/plasmacytoma)
Persistent bone pain (especially in the back or thorax)
renal failure
recurring bacterial infections
Pathologic fractures are common, and vertebral collapse may lead to spinal cord compression and paraplegia.
Symptoms of anemia predominate
Peripheral neuropathy
carpal tunnel syndrome
abnormal bleeding
symptoms of hypercalcemia (eg, polydipsia) are common.
Diagnosis of multiple myeloma (plasma cell myeloma/plasmacytoma)
CBC with platelets, peripheral blood smear, ESR, and chemistry panel (BUN, creatinine, Ca, uric acid, LDH)
Serum and urine protein electrophoresis followed by immunofixation
X-rays (skeletal survey)
Bone marrow examination
Waldenström macroglobulinemia
is a manifestation of lymphoplasmacytic lymphoma, a B-cell neoplasm of lymphoid cells of an intermediate stage between B lymphocytes and plasma cells referred to as plasmacytoid lymphocytes.
In the case of Waldenström macroglobulinemia, the neoplastic cells produce a monoclonal IgM protein (lymphoplasmacytic lymphomas can also occur without protein production).
Defining characteristics
Serum IgM immunoglobulin of either kappa or lambda specificity occurring as an M protein
Plasmacytoid lymphocytes infiltrating the blood, bone marrow, lymph nodes, and spleen
Bence Jones proteinuria in about 10% of cases
Absence of bone lesions
Clinical features of Waldenström macroglobulinemia
Most frequently seen in men older than 50 years of age
Slowly progressive course, often marked by generalized lymphadenopathy and mild anemia
Complications of Waldenström macroglobulinemia
Hyperviscosity syndrome, which results from marked increase in serum IgM. Features include retinal vascular dilation, sometimes with hemorrhage, confusion, and other central nervous system changes. Sometimes, emergency plasmapheresis is required to prevent blindness.
Abnormal bleeding, which may be due to vascular and platelet dysfunction secondary to the serum protein abnormality
Diagnosis of Waldenström macroglobulinemia
CBC with platelets, RBC indices, and peripheral blood smear
Serum protein electrophoresis followed by serum and urine immunofixation
Serum viscosity assay
Bone marrow examination
Sometimes lymph node biopsy
Benign monoclonal gammopathy (monoclonal gammopathy of undetermined significance, or MGUS)
Monoclonal gammopathy of undetermined significance (MGUS) is the production of M-protein by noncancerous plasma cells in the absence of other manifestations typical of multiple myeloma.
The incidence of MGUS increases with age, from 1% of people aged 25 yr to > 5% of people > 70 yr.
MGUS usually is asymptomatic, but peripheral neuropathy can occur.
Although most cases are initially benign, up to 25% (1%/yr) progress to myeloma or a related B-cell disorder, such as macroglobulinemia, amyloidosis, or lymphoma.
Diagnosis is usually suspected when M-protein is incidentally detected in blood or urine during a routine examination.
MGUS is differentiated from other plasma cell disorders because M-protein levels remain relatively stable over time and lytic bone lesions, anemia, and renal dysfunction are absent.
However, patients show enhanced bone loss and a higher rate of fractures. Thus, baseline evaluation with a skeletal survey and bone densitometry should be done.
LYMPHOID NEOPLASMS are…
Lymphomas are a heterogeneous group of tumors arising in the reticuloendothelial and lymphatic systems.
The major types are Hodgkin lymphoma and non-Hodgkin lymphoma
Features of Hodgkins Lymphoma
Nodal involvement: Localized to a specific group of nodes
Spread: Tends to spread in an orderly, contiguous fashion
Effect on Waldeyer’s ring and mesenteric lymph nodes:
Usually does not affect
Extranodal involvement: Infrequent
Stage at diagnosis: Usually early
Histologic classification in children: Usually one with a favorable prognosis
Features of non-hodgkins lymphomas
Nodal involvement: Usually disseminated among > 1 nodal group
Spread: Spreads noncontiguously
Effect on Waldeyer’s ring and mesenteric lymph nodes: Commonly affects mesenteric nodes; May affect Waldeyer’s ring
Extranodal involvement: Frequent
Stage at diagnosis: Usually advanced
Histologic classification in children: Usually high grade
Characteristics, symptoms, diagnosis, and treatment of Hodgkin’s lymphoma
Hodgkin lymphoma is a localized or disseminated malignant proliferation of cells of the lymphoreticular system, primarily involving lymph node tissue, spleen, liver, and bone marrow.
Symptoms include painless lymphadenopathy, sometimes with fever, night sweats, unintentional weight loss, pruritus, splenomegaly, and hepatomegaly.
Diagnosis is based on lymph node biopsy.
Treatment is curative in about 75% of cases and consists of chemotherapy with or without radiation therapy.